Monthly Update3 April 2026 at 10:41 am
Mahamaya Lifesciences Ltd: No Encumbrance Created on Shares by Promoter and Promoter Group in FY 2025-2026
AI Summary
Mahamaya Lifesciences Ltd. has disclosed under Regulation 31(4) of SEBI (SAST) Regulation, 2011, that the Promoter and Promoter Group have not created any encumbrance on their shares during the financial year ended 31% March 2026. This declaration confirms that no shares, directly or indirectly, were encumbered by the members of the Promoter, Promoter group, or persons acting in concert during the aforementioned financial year.
Key Highlights
- Mahamaya Lifesciences Ltd. reports no encumbrance on shares held by Promoter and Promoter Group for FY 2025-2026
- Regulation 31(4) of SEBI (SAST) Regulation, 2011 disclosures received and shared
- No shares directly or indirectly encumbered by Promoter, Promoter group, or persons acting in concert during FY 2025-2026
- Company encourages transparency and compliance with regulatory requirements
- Stakeholders informed of shareholding structure and related updates